Back to search

Article

Immunogenic Cell Death-based prognostic model for predicting the response to immunotherapy and common therapy in lung adenocarcinoma

2022-12-05

Abstract excerpt

Lung adenocarcinoma (LUAD) is a malignant tumor in the respiratory system. The efficacy of current treatment modalities varies greatly, and individualization is evident. Therefore, finding biomarkers for predicting treatment prognosis and providing reference and guidance for formulating treatment options is urgent. Cancer immunotherapy has made distinct progress in the past decades and has a significant effect on...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
39b3ea63-32c7-502d-b448-798885b8bf0d
DOI
10.21203/rs.3.rs-2326199/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Immunogenic Cell Death-based prognostic model for predicting the response to immunotherapy and common therapy in lung adenocarcinomaDOI 10.21203/rs.3.rs-2326199/v1
Identification of Immunogenic cell death-Related Subgroups and Prognosis Model in lung adenocarcinomaSemantic proximity
Expression of Immunogenic Cell Death-Related Genes is Correlated with Immune Microenvironment and Predicts Prognosis in Lung AdenocarcinomaSemantic proximity
Construction of a Novel Damage-Associated Molecular-Pattern-Related Signature to Assess Lung Adenocarcinoma’s Prognosis and Immune LandscapeSemantic proximity
Comprehensive Analysis of Programmed Cell Death Signature in the Prognosis, Tumor Microenvironment and Drug Sensitivity in Lung AdenocarcinomaSemantic proximity
A programmed cell death-related model based on machine learning for predicting prognosis and immunotherapy responses in patients with lung adenocarcinomaSemantic proximity
A novel defined apoptosis-related gene signature as a prognostic tool in lung adenocarcinomaSemantic proximity
An ICD-Associated DAMP Gene signature predicts survival and immunotherapy response of patients with lung adenocarcinomaSemantic proximity
An immune gene signature to predict prognosis and immunotherapeutic response in lung adenocarcinomaSemantic proximity
An Immune Gene Signature for Prediction of Overall Survival and Response to Immune Checkpoint Inhibitors Therapy in Patients with Lung AdenocarcinomaSemantic proximity
Integrated genomic analysis of lung squamous cell carcinoma subtypes characterized by immunogenic cell death-relevant gene signatureSemantic proximity
Identification of a novel necroptosis-related lncRNA-based prognostic model and immunological characteristics of Lung AdenocarcinomaSemantic proximity
An immune indicator based on BTK and DPEP2 identifies hot and cold tumors and clinical treatment outcomes in lung adenocarcinomaSemantic proximity
Select a neighboring publication to make it the new centre.